1fbi: Difference between revisions

No edit summary
No edit summary
Line 4: Line 4:


==Overview==
==Overview==
The crystal structure of the complex between the cross-reacting antigen, Guinea fowl lysozyme and the Fab from monoclonal antibody F9.13.7, raised, against hen egg lysozyme, has been determined by x-ray diffraction to 3-A, resolution. The antibody interacts with exposed residues of an alpha-helix, and surrounding loops adjacent to the lysozyme active site cleft. The, epitope of lysozyme bound by antibody F9.13.7 overlaps almost completely, with that bound by antibody HyHEL10; the same 12 residues of the antigen, interact with the two antibodies. The antibodies, however, have different, combining sites with no sequence homology at any of their, complementarity-determining regions and show a dissimilar pattern of, cross-reactivity with heterologous antigens. Side chain mobility of, epitope residues contributes to confer steric and electrostatic, complementarity to differently shaped combining sites, allowing functional, mimicry to occur. The capacity of two antibodies that have different fine, specificities to bind the same area of the antigen emphasizes the, operational character of the definition of an antigenic determinant. This, example demonstrates that degenerate binding of the same structural motif, does not require the existence of sequence homology or other chemical, similarities between the different binding sites.
The crystal structure of the complex between the cross-reacting antigen Guinea fowl lysozyme and the Fab from monoclonal antibody F9.13.7, raised against hen egg lysozyme, has been determined by x-ray diffraction to 3-A resolution. The antibody interacts with exposed residues of an alpha-helix and surrounding loops adjacent to the lysozyme active site cleft. The epitope of lysozyme bound by antibody F9.13.7 overlaps almost completely with that bound by antibody HyHEL10; the same 12 residues of the antigen interact with the two antibodies. The antibodies, however, have different combining sites with no sequence homology at any of their complementarity-determining regions and show a dissimilar pattern of cross-reactivity with heterologous antigens. Side chain mobility of epitope residues contributes to confer steric and electrostatic complementarity to differently shaped combining sites, allowing functional mimicry to occur. The capacity of two antibodies that have different fine specificities to bind the same area of the antigen emphasizes the operational character of the definition of an antigenic determinant. This example demonstrates that degenerate binding of the same structural motif does not require the existence of sequence homology or other chemical similarities between the different binding sites.


==About this Structure==
==About this Structure==
Line 15: Line 15:
[[Category: Numida meleagris]]
[[Category: Numida meleagris]]
[[Category: Protein complex]]
[[Category: Protein complex]]
[[Category: Alzari, P.M.]]
[[Category: Alzari, P M.]]
[[Category: Lescar, J.]]
[[Category: Lescar, J.]]
[[Category: complex (antibody/antigen)]]
[[Category: complex (antibody/antigen)]]


''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri Feb 15 15:46:59 2008''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 12:37:05 2008''

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA